{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:54:24Z","timestamp":1754110464614,"version":"3.41.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Adequate dosage recommendations are imperative for successful treatment of invasive infections. We evaluated the occurrence of sub- and supratherapeutic serum and cerebrospinal fluid (CSF) concentrations of benzylpenicillin (BPEN) in neonates treated for a severe group B streptococci (GBS) sepsis and\/or meningitis as well as discrepancies in dosing recommendations provided by pediatric reference sources.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective analysis of (pre)term infants treated with BPEN undergoing therapeutic drug monitoring (TDM) between May 2015 and May 2019. Outcomes included numbers of sub- and supratherapeutic concentrations, and dose adjustments, clinical evolution, and dosing recommendations from six pediatric reference sources.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 21 TDM samples from 8 neonates were evaluated. Among serum concentrations, 9\/21 (43%) were below and 8\/21 (38%) above the pre-specified therapeutic target range of 10\u201320\u2009mg\/L. Only 1 patient had BPEN determined in CSF whose concentration was below the lower limit of quantification. TDM identified a need for dose modification in 10\/21 (48%) instances. Three of eight patients exhibited complete resolution of clinical, laboratory and radiologic signs of infection. Substantial variation in dosing recommendations (50,000\u2013400,000 IE\/kg\/d) was present between reference sources.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our data reveal that under current dosage recommendations, the predefined target serum or CSF concentrations of BPEN are not achieved in all children. In case of clinical failure, serum and\/or CSF BPEN concentrations should be determined. Given the wide variation in concentrations and subsequent dose requirements, further exploration of the clinical and pharmacologic characteristics of BPEN in (pre)term neonates is essential to optimize therapeutic efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002993","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T20:47:59Z","timestamp":1605214079000},"page":"434-439","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Benzylpenicillin Serum Concentrations in Neonates With Group B Streptococci Sepsis or Meningitis"],"prefix":"10.1097","volume":"40","author":[{"given":"Sophie J.","family":"Jansen","sequence":"first","affiliation":[{"name":"Neonatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Lopriore","sequence":"additional","affiliation":[{"name":"Neonatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert G. M.","family":"Bredius","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha T.","family":"van der Beek","sequence":"additional","affiliation":[{"name":"Medical Microbiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J. A. R.","family":"Moes","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy and Toxicology, Leiden University Medical Center (LUMC), Leiden, The Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Bekker","sequence":"additional","affiliation":[{"name":"Neonatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1473-3099(14)70919-3","article-title":"Incidence of invasive group G streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study.","volume":"14","author":"Bekker","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CMR.00031-13","article-title":"Early-onset neonatal sepsis.","volume":"27","author":"Simonsen","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"e0214298","DOI":"10.1371\/journal.pone.0214298","article-title":"Epidemiology of neonatal early-onset sepsis in a geographically diverse Australian health district 2006-2016.","volume":"14","author":"Braye","year":"2019","journal-title":"PLoS One"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/pch\/pxz073","article-title":"Early-onset neonatal sepsis: organism patterns between 2009-2014.","volume":"25","author":"Sgro","year":"2020","journal-title":"Paediatr Child Health"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1128\/AAC.01506-06","article-title":"Pharmacokinetics of penicillin g in very-low-birth-weight neonates.","volume":"51","author":"Metsvaht","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(00)90015-1","article-title":"An antibiotic policy to prevent emergence of resistant bacilli.","volume":"355","author":"de Man","year":"2000","journal-title":"Lancet"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/FTD.0b013e318257e8ac","article-title":"A simplified oral flucloxacillin absorption test for patients requiring long-term treatment.","volume":"34","author":"Dijkmans","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/clinids\/17.3.491","article-title":"Clinical pharmacokinetics of continuous intravenous administration of penicillins.","volume":"17","author":"Visser","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/AAC.00318-07","article-title":"Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.","volume":"51","author":"Muller","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"e02238","DOI":"10.1128\/AAC.02238-17","article-title":"Pharmacokinetics of benzylpenicillin in preterm and term neonates.","volume":"62","author":"Padari","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-20250615","first-page":"6207487","article-title":"Therapeutic drug monitoring of meropenem in neonate with necrotizing enterocolitis: a challenge.","volume":"2016","author":"De Keukeleire","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.12741","article-title":"Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.","volume":"80","author":"O\u2019Hara","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/CCM.0b013e3181a0054d","article-title":"A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics.","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3947\/ic.2016.48.2.81","article-title":"Prolonged versus intermittent infusion of \u03b2-lactams for the treatment of nosocomial pneumonia: a meta-analysis.","volume":"48","author":"Lal","year":"2016","journal-title":"Infect Chemother"},{"key":"R27-20250615","first-page":"3178","article-title":"Therapeutic drug monitoring of the \u03b2-lactam antibiotics: what is the evidence and which patients should we be using it for?","volume":"70","author":"Huttner","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:05:05Z","timestamp":1750003505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002993"}},"subtitle":["A Descriptive Cohort Study"],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002993","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2020,11,10]]}}}